Overview
Join Fellow Physicians and Engage in Meaningful Discussion on Clinical Insights, Patient Selection & Safety, and the Regulatory Landscape.
Once again, we are bringing physicians together to dive into the evolving science and best practices of psychedelic medicine. With rising rates of anxiety, depression, PTSD, eating disorders, and chronic pain overwhelming our healthcare system, the need for innovative, effective treatments has never been greater. This evening will be an opportunity to explore how psychedelic therapies are shaping the future of mental health and chronic disease management.
We’ll discuss the latest research, clinical applications, and regulatory advancements—including updates on MAPS MDMA legalization, groundbreaking studies in Canada and Vancouver, and the emerging frameworks guiding safe and effective treatment.
This will be a potluck-style gathering—everyone contributes (by purchasing a ticket), and Mark will arrange Thai or Indian cuisine for the group.
With only 24 seats available and high interest from our 86 invited physicians, this exclusive gathering will fill up fast. Don’t miss your chance to engage in cutting-edge discussions and connect with other forward-thinking doctors who are exploring better ways to treat the complex conditions filling our waiting rooms. Reserve your spot today!
Why Attend?
Clinical Insights – Stay informed about the legalization of MAPS MDMA, Canadian and Vancouver-based initiatives, and recent research findings.
Patient Selection & Safety – Discuss best practices for identifying appropriate patients and ensuring safe, effective treatment protocols.
Regulatory Landscape – Understand the evolving framework for psychedelic-assisted therapy in Canada.
Peer Collaboration – Engage in meaningful discussions with fellow physicians about how this emerging field fits into modern medical practice.
Agenda
6:30 PM - 7:30 PM: Doors Open
Get acquainted and settle into the space.
7:00 PM - 8:30 PM Dinner & Discussion: Advancing Psychedelic Medicine
We’ll discuss the latest research, clinical applications, and regulatory advancements—including updates on MAPS MDMA legalization, groundbreaking studies in Canada and Vancouver, and the emerging frameworks guiding safe and effective treatment.
8:30 PM - 9:00 PM: Closing Remarks
Discussion winds down and we say our farewells.
Mark Haden
Clinical Supervisor
Psychedelic Therapy Programs at Qi Integrated Health
A major figure in the field of psychedelic medicines, Mark has published numerous articles in respected Journals, has presented at conferences and training events around the world.